Loading company…
Padlock Therapeutics is a Cambridge, US biopharmaceutical company developing treatments for autoimmune diseases.
Padlock Therapeutics is a biopharmaceutical company in Cambridge, US, working on treatments for autoimmune diseases such as rheumatoid arthritis and lupus. Founded in 2014, it is at the Series A stage and has completed 4 deals. Its most recent deal was a trade sale to Bristol-Myers Squibb on March 23, 2016, for USD 225.00 mn, completed in April 2016.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in